Ralphs cuts generic drug prices FDA grants tentative approval to Taro for Lamotrigine Further restrictions placed on Novartis’ treatment for irritable bowel syndrome FDA closer to being given responsibility of tobacco regulation Schering-Plough announces $1 billion in cuts, cites damaging study Association publication cites NACDS as a top lobbying group NACDS urges prescribers to obtain NPI, expresses concerns on drug delays Generic drugs get $4 price at Kroger FDA grants orphan designation for MELAS syndrome drug CMS issues final e-prescribing rules for Part D First Previous 2531 2532 2533 2534 2535 Next Last
